Skip to main content

Bayesian Capital Management, LP

SEC CIK
0001632551
Latest filing
Aug 14, 2026

PFE holding history

Pfizer Inc in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of PFE by Bayesian Capital Management, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−46,700−100.0%Sold outHolders
Q1 202646,700$1.31M1.6%+46,700NewHolders
Q3 20250$00.0%−98,200−100.0%Sold outHolders
Q2 202598,200$2.38M0.4%−55,000−35.9%ReducedHolders
Q1 2025153,200$3.88M0.6%−28,400−15.6%ReducedHolders
Q4 2024181,600$4.82M0.6%+40,800+29.0%AddedHolders
Q3 2024140,800$4.07M0.5%+85,700+155.5%AddedHolders
Q2 202455,100$1.54M0.2%−164,900−75.0%ReducedHolders
Q1 2024220,000$6.11M0.6%+44,800+25.6%AddedHolders
Q4 2023175,200$5.04M0.5%+63,600+57.0%AddedHolders
Q3 2023111,600$3.70M0.4%+51,300+85.1%AddedHolders
Q2 202360,300$2.21M0.2%+35,800+146.1%AddedHolders
Q1 202324,500$999.6K0.1%+24,500NewHolders
Q3 20220$00.0%−18,400−100.0%Sold outHolders
Q2 202218,400$965.0K0.2%+18,400NewHolders
Q1 20220$00.0%−6,000−100.0%Sold outHolders
Q4 20216,000$354.0K0.1%−28,900−82.8%ReducedHolders
Q3 202134,900$1.50M0.4%−800−2.2%ReducedHolders
Q2 202135,700$1.40M0.4%−60,644−62.9%ReducedHolders
Q1 202196,344$3.49M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.